search
Back to results

Paleolithic Diet in the Treatment of Diabetes Type 2 in Primary Health Care

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Phase 2
Locations
Sweden
Study Type
Interventional
Intervention
Paleolithic diet
Sponsored by
Lund University Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 2

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults with capacity to perform study
  • Diabetes Mellitus Type 2
  • C-peptide > 0
  • HbA1C >5.5
  • Unchanged diabetes treatment during last 3 months
  • Weight and HbA1C varied less than 5% during last 3 months
  • No acute heart disease during last 6 months
  • Unchanged treatment with betablocker last 6 months
  • Unchanged treatment with thyroid hormone substitution last 6 months

Exclusion Criteria:

  • Treatment with insulin
  • Chronic treatment with steroids (not inhaled)
  • Treatment with Waran (anticoagulant cumarin type)
  • Creatinin > 130 micromol/L
  • Elevated liver enzymes (ALAT,ASAT,ALP or GT > 4 X upper reference value)
  • Acute heart disease
  • Changed treatment with betablocker or thyroid hormone substitution

Sites / Locations

  • Lund University Hospital

Outcomes

Primary Outcome Measures

area under the curve for glucose (AUC Glucose0-120) at the oral glucose tolerance test at baseline, 3 months and 6 months
area under the curve for insulin (AUC Insulin0-120) at the oral glucose tolerance test at baseline, 3 months and 6 months
HbA1C at baseline, 3 months and 6 months
weight at baseline, 3 months and 6 months
waist circumference at baseline, 3 months and 6 months

Secondary Outcome Measures

satiation measured on visual semi-analogous scale at food intake during 4 days av 6 weeks and 12 weeks
leptin at baseline, 3 months and 6 months
fasting plasma glucose at baseline, 3 months and 6 months
fasting plasma insulin at baseline, 3 months and 6 months
Systolic and diastolic blod pressure at baseline, 3 months and 6 months
Blood lipids at baseline, 3 months and 6 months
C-reactive protein at baseline, 3 months and 6 months

Full Information

First Posted
February 13, 2007
Last Updated
May 13, 2008
Sponsor
Lund University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00435240
Brief Title
Paleolithic Diet in the Treatment of Diabetes Type 2 in Primary Health Care
Study Type
Interventional

2. Study Status

Record Verification Date
May 2008
Overall Recruitment Status
Completed
Study Start Date
January 2005 (undefined)
Primary Completion Date
September 2007 (Actual)
Study Completion Date
September 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Lund University Hospital

4. Oversight

5. Study Description

Brief Summary
There is uncertainty about the optimal diet in the prevention and treatment of diabetes type 2. Earlier studies have generally focused on intakes of fat, protein, carbohydrate, fiber, fruit and vegetables. This study is based on another approach which compares foods that were available during human evolution with more recently introduced ones. The basic tenet from evolutionary biology is that if human physiology is less adapted to a relatively recently introduced diet based on agriculture, this could cause disturbances to human physiology and ultimately lead to diseases. Epidemiological studies indicates that diabetes mellitus type 2 is absent or near absent in populations eating a Palaeolithic ("Old Stone Age") diet which is free from food items produced in agriculture or the food industry. Our study hypothesis is that a Palaeolithic diet is better than the standard diabetes diet recommended today in treating diabetes type 2. Fifteen patients with diabetes type 2 have been randomized to a Palaeolithic diet based on lean meat, fish, fruit, vegetables, root vegetables, eggs, and nuts a standard diabetes diet as recommended by national health authorities. The patients eat the diet they have been randomized to for three months and then switches to the other diet for another three months. The study is conducted in Primary Health Care stations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Paleolithic diet
Primary Outcome Measure Information:
Title
area under the curve for glucose (AUC Glucose0-120) at the oral glucose tolerance test at baseline, 3 months and 6 months
Title
area under the curve for insulin (AUC Insulin0-120) at the oral glucose tolerance test at baseline, 3 months and 6 months
Title
HbA1C at baseline, 3 months and 6 months
Title
weight at baseline, 3 months and 6 months
Title
waist circumference at baseline, 3 months and 6 months
Secondary Outcome Measure Information:
Title
satiation measured on visual semi-analogous scale at food intake during 4 days av 6 weeks and 12 weeks
Title
leptin at baseline, 3 months and 6 months
Title
fasting plasma glucose at baseline, 3 months and 6 months
Title
fasting plasma insulin at baseline, 3 months and 6 months
Title
Systolic and diastolic blod pressure at baseline, 3 months and 6 months
Title
Blood lipids at baseline, 3 months and 6 months
Title
C-reactive protein at baseline, 3 months and 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults with capacity to perform study Diabetes Mellitus Type 2 C-peptide > 0 HbA1C >5.5 Unchanged diabetes treatment during last 3 months Weight and HbA1C varied less than 5% during last 3 months No acute heart disease during last 6 months Unchanged treatment with betablocker last 6 months Unchanged treatment with thyroid hormone substitution last 6 months Exclusion Criteria: Treatment with insulin Chronic treatment with steroids (not inhaled) Treatment with Waran (anticoagulant cumarin type) Creatinin > 130 micromol/L Elevated liver enzymes (ALAT,ASAT,ALP or GT > 4 X upper reference value) Acute heart disease Changed treatment with betablocker or thyroid hormone substitution
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tommy Jönsson, MD
Organizational Affiliation
Department of Clinical Sciences, Lund University, Lund Sweden
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lund University Hospital
City
Lund
State/Province
Skåne
ZIP/Postal Code
22185
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
17081292
Citation
Jonsson T, Ahren B, Pacini G, Sundler F, Wierup N, Steen S, Sjoberg T, Ugander M, Frostegard J, Goransson L, Lindeberg S. A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs. Nutr Metab (Lond). 2006 Nov 2;3:39. doi: 10.1186/1743-7075-3-39.
Results Reference
background
PubMed Identifier
16336696
Citation
Jonsson T, Olsson S, Ahren B, Bog-Hansen TC, Dole A, Lindeberg S. Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance? BMC Endocr Disord. 2005 Dec 10;5:10. doi: 10.1186/1472-6823-5-10.
Results Reference
background
PubMed Identifier
15699220
Citation
Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005 Feb;81(2):341-54. doi: 10.1093/ajcn.81.2.341.
Results Reference
background
PubMed Identifier
27216013
Citation
Fontes-Villalba M, Lindeberg S, Granfeldt Y, Knop FK, Memon AA, Carrera-Bastos P, Picazo O, Chanrai M, Sunquist J, Sundquist K, Jonsson T. Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial. Cardiovasc Diabetol. 2016 May 23;15:80. doi: 10.1186/s12933-016-0398-1.
Results Reference
derived
PubMed Identifier
19604407
Citation
Jonsson T, Granfeldt Y, Ahren B, Branell UC, Palsson G, Hansson A, Soderstrom M, Lindeberg S. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovasc Diabetol. 2009 Jul 16;8:35. doi: 10.1186/1475-2840-8-35.
Results Reference
derived

Learn more about this trial

Paleolithic Diet in the Treatment of Diabetes Type 2 in Primary Health Care

We'll reach out to this number within 24 hrs